Tag Archives: Acquired Hemophilia Treatment Market

Acquired hemophilia develops in patients with no previous history. In the U.S. the disorder affects approximately 2.1 individuals per 1,000,000 per year, whereas in the U.K. acquired hemophilia occurs in 1.4 individuals per 1,000,000 per year. It is also opined that several patients may go misdiagnosed or undiagnosed thus making the exact prevalence difficult to determine. Although acquired hemophilia predominantly ...

The Acquired Hemophilia Treatment Market is anticipated to grow at a compound annual growth rate of 3.3% for the forecast period of 2021 to 2029. The rise is mainly due to increased rate of acquired hemophilia clinical testing. Acquired Hemophilia (AH) is a rare auto-immune bleeding disorder that significantly limits the body’s ability to form a clot after a hemorrhage. It affects ...